Posted Jan. 4, 2013 at 6:55 a.m.

Premium Lock Tranzyme could be in for big paydays from drug giant Bristol-Myers

Published: 2013-01-04 06:55:00
Updated: 2013-01-04 06:55:00


Tranzyme Pharma, its stock driven under $1 a share in value by recent drug setbacks, reported some good news early Friday - the transfer of several compounds to Bristol-Myers Squibb that could lead to big paydays....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Latest for Insiders